摘要
Medical artificial intelligence(AI)is an important technical asset to support medical supply-side reforms and national development in the big data era.Clinical data from multiple disciplines represent building blocks for the development and application of AI-aided diagnostic and treatment systems based on medical big data.However,the inconsistent quality of these data resources in AI research leads to waste and inefficiencies.Therefore,it is crucial that the field formulatesthe requirements and content related to data processing as part of the development of intelligent medicine.To promote medical AI research worldwide,the“Belt and Road”International Ophthalmic Artificial Intelligence Research and Development Alliance will establish a series of expert recommendations for data quality in intelligent medicine.
基金
The Science and Technology Planning Projects of Guangdong Province(2018B010109008)
National Key R&D Program of China(2018YFC0116500).